SCHEMBL19334643

SCHEMBL19334643

CCC(O)C(O)CCC(O)C(O)CCC(C)O

nearest known ligand 0.50

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.50
TDP1 Q9NUW8 1/20 0.35
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
TRPA1 O75762 2/20 0.32
SPHK1 Q9NYA1 1/20 0.31
TRPV1 Q8NER1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16323429 0.94 TSHR (0.56) TSHRTDP1ALDH1A1LMNATRPA1
SCHEMBL10864142 0.83 TSHR (0.45) TSHRTDP1ALDH1A1LMNATRPA1
SCHEMBL5175266 0.82 TSHR (0.42) TSHRLMNATRPA1SPHK1TRPV1
SCHEMBL7219024 0.80 LMNA (0.48) TSHRTDP1ALDH1A1LMNASPHK1
SCHEMBL16078621 0.78 SPHK1 (0.48) TSHRALDH1A1LMNATRPA1SPHK1
SCHEMBL3747066 0.77
SCHEMBL2985874 0.77
SCHEMBL106122 0.77
SCHEMBL789937 0.77
SCHEMBL10076291 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9757385-B2 Method of treating leukemia using pharmaceutical formulation containing thienotriazolodiazepine compounds MERCK SHARP & DOHME CORP. (US) 2017-09-12 US disclosed